Cargando…
Letter: The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone (Diabetes Metab J 2012;36:371-8)
Autor principal: | Kim, Sang-Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Diabetes Association
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3530717/ https://www.ncbi.nlm.nih.gov/pubmed/23275940 http://dx.doi.org/10.4093/dmj.2012.36.6.460 |
Ejemplares similares
-
Letter: The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone (Diabetes Metab J 2012;36:371-8)
por: Li, Sheyu, et al.
Publicado: (2013) -
Response: The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone (Diabetes Metab J 2012;36:371-8)
por: Kim, Kwang Joon, et al.
Publicado: (2013) -
Response: The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone (Diabetes Metab J 2012;36:371-8)
por: Song, Sun Ok, et al.
Publicado: (2012) -
Letter: Prevalence and Correlates of Disordered Sleep in Southeast Asian Indians with Type 2 Diabetes (Diabetes Metab J 2012;36:70-6)
por: Kawada, Tomoyuki
Publicado: (2012) -
Letter: Prevalence of Dyslipidemia among Korean Adults: Korea National Health and Nutrition Survey 1998-2005 (Diabetes Metab J 2012;36:43-55)
por: Koo, Bo Kyung
Publicado: (2012)